In Vitro Activity, Stability and Molecular Characterization of Eight Potent Bacteriophages Infecting

Abeer Ameen Baqer1,2, Kokxin Fang2, Norfarhan Mohd-Assaad3,4

  • 1Medical Laboratory Techniques Department, Dijlah University College, Baghdad 10021, Iraq.

Viruses
|January 21, 2023
PubMed
Abstract

Insights

Eight bacteriophages were characterized for their effectiveness against carbapenem-resistant Klebsiella pneumoniae. These lytic bacteriophages demonstrated high stability and lytic efficiency, showing great potential for phage therapy against resistant bacterial infections.

Area of Science:

  • Microbiology
  • Virology
  • Infectious Diseases

Background:

  • Klebsiella species are leading causes of hospital-acquired infections.
  • Rising antimicrobial resistance necessitates alternative treatments like bacteriophage therapy.
  • Bacteriophages offer a safe and effective therapeutic approach for bacterial infections.

Purpose of the Study:

  • To characterize eight lytic bacteriophages against carbapenem-resistant Klebsiella pneumoniae.
  • To evaluate the stability, lytic ability, and molecular profiles of these bacteriophages.
  • To assess their potential as therapeutic agents.

Main Methods:

  • One-step-growth curves, stability assays, and lytic activity assessments.
  • Molecular characterization using Restriction Fragment Length Polymorphism (RFLP) and Random Amplification of Polymorphic DNA (RAPD) typing.
  • Protein profiling via SDS-PAGE and phylogenetic analysis of key proteins.

Main Results:

  • All eight bacteriophages exhibited high bacterial reduction efficiency and stability under various conditions.
  • SDS-PAGE revealed four major protein bands (15-190 KDa), likely head and tail proteins.
  • Genomes were double-stranded DNA (dsDNA) ranging from 36-87 Kb.
  • Bacteriophages rapidly reduced optical density of planktonic K. pneumoniae.

Conclusions:

  • Tail fiber protein analysis effectively distinguished closely related bacteriophages.
  • The characterized bacteriophages show significant promise for phage therapy against carbapenem-resistant K. pneumoniae.
  • These findings support bacteriophage therapy as a viable strategy against multidrug-resistant bacteria.